In Vivo Pharmacodynamic Imaging of Proteasome Inhibition
Inhibiting the proteolytic activity of the 26S proteasome has been shown to have selective apoptotic effects on cancer cells and to be clinically efficacious in certain malignancies. There is an unmet medical need for additional proteasome inhibitors, and their development will be facilitated by sur...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications
2009-05-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.2310/7290.2009.00007 |